• Bone Health
  • Immunology
  • Hematology
  • Respiratory
  • Dermatology
  • Diabetes
  • Gastroenterology
  • Neurology
  • Oncology
  • Ophthalmology
  • Rare Disease
  • Rheumatology

Poll: What Is Your Prediction for 2021?

Article

The year 2021 could bring momentous developments in the biosimilar field.

Which do you think is most likely to occur in 2021?

The Supreme Court strikes down the whole Affordable Care Act and its biosimilar approval pathway.
The FDA approves the first insulin biosimilar.
Innovator companies launch lower-cost "authorized biologics" in response to biosimilar competition.
The FDA approves the first interchangeable biosimilar.

See what our Advisory Board had to say about 2020 and 2021 in biosimilars.

Recent Videos
 Here are the top 5 biosimilar articles for the week of July 15, 2024.
Jeffrey Casberg, MS, RPh
Here are the top 5 biosimilar articles for the week of July 8, 2024.
Here are the top 5 biosimilar articles for the week of July 1, 2024.
Jeffrey Casberg, RPh, MS.
Here are the top 5 biosimilar articles for the week of June 24, 2024.
Jeffrey Casbery, IPD Analytics
Here are the top 5 biosimilar articles for the week of June 17, 2024.
Here are the top 5 biosimilar articles for the week of June 10, 2024.
Lakesha Farmer, PharmD
Related Content
© 2024 MJH Life Sciences

All rights reserved.